Canada markets close in 3 hours 49 minutes

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.11000.0000 (0.00%)
As of 11:55AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 56.23M
Enterprise Value 11.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.84
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.13

Trading Information

Stock Price History

Beta (5Y Monthly) 1.75
52-Week Change 3-59.64%
S&P500 52-Week Change 3-8.00%
52 Week High 33.0300
52 Week Low 30.5000
50-Day Moving Average 30.9265
200-Day Moving Average 31.1329

Share Statistics

Avg Vol (3 month) 3305.44k
Avg Vol (10 day) 3161.92k
Shares Outstanding 548.06M
Implied Shares Outstanding 6N/A
Float 824.46M
% Held by Insiders 116.56%
% Held by Institutions 162.36%
Shares Short (Jan 12, 2023) 4362.24k
Short Ratio (Jan 12, 2023) 41.27
Short % of Float (Jan 12, 2023) 41.01%
Short % of Shares Outstanding (Jan 12, 2023) 40.75%
Shares Short (prior month Dec 14, 2022) 4322.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-64.98%
Return on Equity (ttm)-197.73%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-95.24M
Diluted EPS (ttm)-4.0020
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.38M
Total Cash Per Share (mrq)0.99
Total Debt (mrq)2.56M
Total Debt/Equity (mrq)26.59
Current Ratio (mrq)1.19
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-89.14M
Levered Free Cash Flow (ttm)-30.42M